Inhibitors of cytochrome P-450 reduce cyclic GMP stimulation by glyceryl trinitrate in LLC-PK1 kidney epithelial cells

Henning Schröder, Karsten Schrör

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


The inhibitor of cytochrome P-450 cimetidine was used to asses the role of cytochrome P-450-dependent enzymes for cyclic GMP stimulation by glyceryl trinitrate in a kidney epithelial cell line (LLC-PK1). Pretreatment of the cells with 0.1 mmol/1 cimetidine markedly decreased cyclic GMP stimulation by glyceryl trinitrate (0.03 -1 μmol/l). In the presence of 0.1 mmol/1 cimetidine, the 14-fold cyclic GMP stimulation observed at 1 μmol/l glyceryl trinitrate was reduced by 66%. Glyceryl trinitrate-induced cyclic GMP stimulation remained unaltered by ranitidine (0.1 mmol/1), which has a much lower affinity for the cytochrome P-450 enzyme system. Another inhibitor of cytochrome P-450, miconazole (0.1 mmol/1), also attenuated glyceryl trinitrate-induced cyclic GMP stimulation. In contrast, cimetidine and miconazole did not affect cyclic GMP stimulation by sodium nitroprusside that spontaneously releases nitric oxide. These results suggest that in intact cells, glyceryl trinitrate-induced cyclic GMP stimulation is dependent on cytochrome P-450 enzymes which may be relevant for nitric oxide formation from organic nitrates.

Original languageEnglish (US)
Pages (from-to)616-618
Number of pages3
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Issue number5
StatePublished - Nov 1990


  • Cyclic GMP
  • Cytochrome P-450
  • Glyceryl trinitrate
  • Kidney epithelial cells
  • Nitric oxide

Fingerprint Dive into the research topics of 'Inhibitors of cytochrome P-450 reduce cyclic GMP stimulation by glyceryl trinitrate in LLC-PK<sub>1</sub> kidney epithelial cells'. Together they form a unique fingerprint.

Cite this